{
  "case_id": "EI23-40395",
  "year": 2023,
  "patient_info": {
    "age_range": "51 to 64",
    "gender": "Male"
  },
  "diagnosis": "CNS/ Neuromusc Dis",
  "secondary_conditions": [],
  "complications": [],
  "symptoms": [],
  "treatment_category": "Diag Imag & Screen",
  "treatment_subcategory": "PET Scan",
  "treatments_requested": [
    {
      "name": "Brain PET Scan",
      "drug_type": null,
      "procedure_type": "imaging",
      "is_procedure": true,
      "other_or_notes": "Experimental/Investigational"
    }
  ],
  "treatments_tried_but_failed": [],
  "treatments_tried_and_worked": [],
  "treatments_not_tried": [],
  "is_denial_upheld": false,
  "issues_considered": [
    "medical_necessity",
    "diagnosis",
    "plan_coverage"
  ],
  "other_issues": null,
  "guidelines_support": null,
  "guidelines_not_support": null,
  "guidelines_details": null,
  "soc_support": null,
  "soc_not_support": null,
  "soc_details": null,
  "study_support": true,
  "study_details": [
    {
      "study_name": "Advances in PET Imaging for Dementia",
      "study_authors": "Researchers",
      "key_findings": "PET imaging identifies therapeutic targets and discriminates between dementias. Nuclear medicine imaging aids in diagnosis and understanding of dementia."
    }
  ],
  "key_questions": [
    "medical_necessity",
    "confirm_diagnosis"
  ],
  "expedited": false,
  "rationale": "The requested brain PET scan is likely to be more beneficial for evaluating the patient's condition than any available standard therapy. The Health Plan's denial should be overturned.",
  "reviewer_credentials": "Physician reviewer 1: Board certified in neurology, sub-specialty in clinical neurophysiology. Physician reviewers 2 and 3: Board certified in neurology, sub-specialty in vascular neurology. All actively practicing and experts in the treatment of the enrollee\u2019s condition."
}